For the Inventor, By the Inventor

Enter assignee name

Leuven, Bulgaria

Leuven Research & Development Vzw

Calculating rank

USPTO Granted Patents = 26

% Expired Patents = 19.2

Forward Citations = 284

Loading Chart...

Loading Chart...

24 inventors (with patents filed for the assignee):

Paul N Holvoet (9 out of 10 patents)

Desire J Collen (9 out of 11 patents)

Désiré José Collen (3 out of 4 patents)

4. Désiré J Collen (2 out of 3 patents)

5. Adrien Edgard Cremers (2 out of 2 patents)

6. Andre Petrus Maes (2 out of 2 patents)

7. Lucas J Delaey (2 out of 2 patents)

8. Jean-Marie Saint-Remy (1 out of 41 patents)

9. Marc G Jacquemin (1 out of 13 patents)

10. Desire Jose Collen (1 out of 1 patent)

11. Désiré José Collen (1 out of 2 patents)

12. Désire José Collen (1 out of 1 patent)

13. Désiré José Collen (1 out of 1 patent)

14. Désiré J Collen (1 out of 1 patent)

15. Jozef Leonia Pleysier (1 out of 1 patent)

Core Competencies:

Coronary Artery Disease

Thrombolytic Activity

Oxidized LDL Detection

Staphylokinase Derivatives

Pharmaceutical Composition

Allergy Treatment

Copper-Zinc-Aluminium Alloys

Thrombosis Test

Blood Plasma Analysis

Metal Recovery

Assays

Antibodies

26 patents: Sort by Forward Citations

1. 7604952 - Detection and determination of the stages of coronary artery disease (2009-10-20),

2. 7579159 - Assays, antibodies, and standards for detection of oxidized and MDA-modified low density lipoproteins (2009-08-25),

3. 7390627 - Assays, antibodies, and standards for detection of oxidized and MDA-modified low density lipoproteins (2008-06-24),

4. 7378250 - Assays, antibodies, and standards for detection of oxidized and MDA-modified low density lipoproteins (2008-05-27),

5. 7229776 - Assays, antibodies, and standards for detection of oxidized and MDA-modified low density lipoproteins (2007-06-12),

6. 7229775 - Assays, antibodies, and standards for detection of oxidized and MDA-modified low density lipoproteins (2007-06-12),

7. 7166469 - Detection and determination of the stages of coronary artery disease (2007-01-23),

8. 6902733 - Staphylokinase derivatives with polyethyleneglycol (2005-06-07),

9. 6727102 - Assays, antibodies, and standards for detection of oxidized and MDA-modified low density lipoproteins (2004-04-27),

10. 6602509 - Compound and method for the prevention and/or the treatment of allergy (2003-08-05),

11. 6309888 - Detection and determination of the stages of coronary artery disease (2001-10-30),

12. 5951980 - Identification, production and use of new staphylokinase derivatives (1999-09-14),

13. 5695754 - Staphylokinase derivatives (1997-12-09),

14. 5174994 - Pharmaceutical composition having thrombolytic activity (1992-12-29),

15. 4752603 - Plasminogen activator and pharmaceutical composition having thrombolytic (1988-06-21),

Company Overview

Leuven Research & Development Vzw is a prominent research organization based in Leuven, Belgium, specializing in the development and commercialization of innovative technologies. The organization focuses on various domains, including advanced materials, biotechnology, and information technology, fostering collaboration between academia and industry. By leveraging cutting-edge research, Leuven Research & Development aims to drive technological advancements and support the growth of startups and established companies in the region.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

26 Patents

#1 in Leuven

#1 in Bulgaria

#24,848 in the World

Leuven, Bulgaria

Leuven Research & Development Vzw

Forward Citations = 284

24 inventors:

Paul N Holvoet (9 out of 10 patents)

Desire J Collen (9 out of 11 patents)

Désiré José Collen (3 out of 4 patents)

4. Désiré J Collen (2 out of 3 patents)

5. Adrien Edgard Cremers (2 out of 2 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Leuven Research & Development Vzw. Retrieved from https://idiyas.com/company/leuven-research-and-development-vzw

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…